Impact of treatment strategy after malignant bowel obstruction in stage IV gastrointestinal cancer: population-based cohort study
Ribeiro T, Bondzi-Simpson A, Bateni S, Chan WC, Coburn N, Law C, Hallet J. BJS Open. 2026; 10(1):zraf171.
Publications
Short- and long-term healthcare costs attributable to hepatitis B among newcomers to Ontario, Canada: a matched cohort study
Anyiwe K, Feld JJ, Pullenayegum E, Wong WWL, Nguyen L, Sander B. Can J Gastroenterol Hepatol. 2026; 2026(1): e2330427.
Did COVID-19 worsen the disparities among mental health patients at risk of exhibiting aggression in Ontario, Canada?
Ghazalbash S, Verter V. Health Care Manag Sci. 2026; 29(1): 3.
Palliative care delivery in the last year of life among ethnically South Asian Canadians in Ontario, Canada
Ambady L, Jia Z, Kurahashi AM, Qureshi F, Govindarajan A, Sharma RK, Quinn KL. J Immigr Minor Health. 2026; 28(2): 505-511. Epub 2026 Feb 2.
Short- and long-term healthcare costs attributable to hepatitis B among newcomers to Ontario, Canada: a matched cohort study
Anyiwe K, Feld JJ, Pullenayegum E, Wong WWL, Nguyen L, Sander B. Can J Gastroenterol Hepatol. 2026; Feb 2.
The impact of inter-hospital transfer before endovascular thrombectomy on long-term outcomes after acute ischemic stroke
Murphy RP, Hong Z, Fang J, Austin PC, Kapral MK, Yu AYX. Can J Neurol Sci. 2026; Jan 30 [Epub ahead of print].
Impact of adolescent and young adult cancer expertise in oncologists on AYA outcomes in Hodgkin lymphoma: a population-based study in Ontario, Canada
Andrew EC, Lau C, Rae C, Barr RD, Nathan PC, Gupta S. Cancer Med. 2026; 15(2): e71549.
Measuring the impact of the substitution of innovator biologics with biosimilars on uptake and costs among Ontario public drug benefit recipients
Iacono A, Ho M, Yang J, Campbell T, Wynne W, Shearer D, Andersen L, Majer E, Ledlie S, Tadrous M, Gomes T. Clin Pharmacol Ther. 2026; Jan 27 [Epub ahead of print].
Impact of depression on TAVR wait time and post-TAVR outcomes: a population-based study
Abu Ghosh Z, Qiu F, Manoragavan R, Tam DY, Ko DT, Wijeysundera HC, Sud M. Eur Heart J Open. 2026; 6(1): oeag010.
Healthcare utilization patterns and costs related to neurofibromatosis 1 in Ontario, Canada
Sivadasan A, Hernandez A, Candido E, Parkin PC, Tu K, Mendoza M, Barnett-Tapia C. Orphanet J Rare Dis. 2026; 21(1): 25.